(HealthDay News) — The percentage of U.S. adults using nicotine pouches remains low, according to a research letter published online Sept. 8 in JAMA Network Open.

Rare pathogenic variants in cancer predisposition genes increase the risk of developing single and multiple primary cancers, researchers found.

Lowest representation seen for studies on arrhythmia, coronary heart disease, acute coronary syndrome, and heart failure.

Early prediction and prevention of venous thromboembolism is crucial in high-risk populations, such as hospitalized patients with bladder cancer.

Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately.

Artificial neural networks based on these biomarkers demonstrated strong predictive ability for AAV risk, validated across multiple data sets and patient renal biopsy samples.

The FDA has approved Enbumyst, a nasal spray formulation of bumetanide, for the treatment of edema associated CHF, and hepatic and renal disease.